Search Results

Results 1 - 10 of 61 for child health. (1.38 seconds)
  • Myelination may drive drug addiction

    New research in mice by Stanford Medicine scientists has found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids.

  • Studying neurodevelopmental disorders

    Stanford Medicine research on Timothy syndrome — which predisposes newborns to autism and epilepsy — may extend well beyond the rare genetic disorder to schizophrenia and other conditions.

  • New epilepsy target

    Researchers find that a little-understood part of the brain appears to be involved in starting seizures and keeping them going.

  • Women’s and men’s brain patterns differ

    Stanford Medicine researchers have developed a powerful new artificial intelligence model that can distinguish between male and female brains.

  • Cancer neuroscience discoveries give hope

    To drive their growth, many tumors hijack nervous system signals, including those needed for brain plasticity. Stanford Medicine discoveries are opening a promising new branch of oncology research.

  • Memory in general hindered in autism

    Memory impairment in autism goes beyond poor facial recognition, a Stanford Medicine team showed. The finding suggests a wide role for memory in the neurobiology of the disorder.

  • Autism hinders grasp of vocal emotion

    Children with autism have trouble identifying emotional tones because of differences in a brain region that processes social information, a Stanford Medicine study found.

  • $10 million for autism, sleep research

    About 80% of children with autism have trouble sleeping, but whether better sleep could lessen other autism symptoms is unknown. A new grant will help Stanford Medicine scientists find out.

  • Epilepsy linked to mood symptoms in pregnancy

    Stanford-led study gives new insight into how epilepsy, pregnancy and symptoms of mood disorders interact.

  • COVID-19 brain fog similar to chemo brain

    Researchers found that damage to the brain’s white matter after COVID-19 resembles that seen after cancer chemotherapy, raising hope for treatments to help both conditions.